Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/235e662e-185f-49ad-9a2e-3948a28de472/

PNTG

Pennant Group Inc
Chart
41.95 USD
Latest Week 2026-07-17
HealthcareMedical Care FacilitiesSMALL
Snapshot 2026-07-19 · 0.6w · Fresh
0.12
OS Score
9.0%
Value
13.0%
Quality
88.0%
Momentum
3/9
F-Score
0.108
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
4 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
P/S 1.4
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
Yes
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
12-1 43%
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
RAM 1.11
V
Value Analysis
Cheapness relative to fundamentals
9.0%ile
P/E
48.1×
P/S
1.4×
P/B
4.2×
E/P
0.0260
FCF Yield
0.048
EBITDA/EV
0.031
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
89.00000000
/100 — 1=cheapest
VC2 (Trending Value)
92.00000000
/100
VC3 (Buyback)
92.00000000
/100
P/E of 48.1x is premium-priced — the market is paying up for expected growth. VC2 score of 92.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
13.0%ile
ROE
0.088
ROA
0.032
Net Margin
0.030
Op Margin
0.050
GPA
0.158
D/E
1.64
Current
1.19
F-Score
3/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.368
Earn Growth
0.192
Stability
0.174
lower=better
Accruals
-0.037
lower=better
5yr Consist
Yes
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
88.0%ile
6M Return
43.9%
12M Return
79.0%
12-1 Mom
42.7%
Risk-Adj
1.11
Vol 252d
38.6%
Vol 60d
77.3%
↑ Expanding
Max DD 12M
-12.0%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 43% is very strong — a clear uptrend. Near-term vol (77%) is expanding vs long-term (39%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.12
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 500 peers
Sector Value %ile
3.8%
Sector Quality %ile
2.0%
P/E z-score
0.37
P/B z-score
-0.12
Sector Avg OS
64.1%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
FBIOP Fortress Biotech Inc Pref Series A 99.0% 98.0% 84.0% 96.0%
IRWD Ironwood Pharmaceuticals Inc 99.0% 92.0% 91.0% 98.0%
CGEN Compugen 98.0% 89.0% 96.0% 82.0%
RIGL Rigel Pharmaceuticals Inc 98.0% 90.0% 93.0% 93.0%
FBIO Fortress Biotech Inc 98.0% 98.0% 84.0% 88.0%
NUTX Nutex Health Inc 98.0% 91.0% 98.0% 80.0%
TBPH Theravance Biopharma Inc 98.0% 90.0% 99.0% 84.0%
MD Mednax Inc 97.0% 85.0% 84.0% 93.0%
Factor Interactions
Volatility Expanding
60-day vol (77%) significantly exceeds 252-day (39%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
D
34.1% avg (7 factors)
Quality
D
36.1% avg (8 factors)
Momentum
A
83.8% avg (4 factors)
Risk
C
52.4% avg (1 factors)
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends7 snapshots
Factor Persistence7 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.120—7—
Value %ile0.090—7—
Quality %ile0.130—7—
Momentum %ile0.880—3—
F-Score3.000—7—
Confidence0.910—7—
Volatility0.386—0—
Value Lens2021-07-20 → 2026-07-19
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
48.10
Earnings Yield (E/P)
0.0260
Price / Sales
1.43
Price / Book
4.22
Price / Cash Flow
22.06
FCF Yield
4.8%
EBITDA / EV
3.1%
Sales Yield (1/P·S)
0.5248
Shareholder Yield
Div + net buyback / mktcap
-0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
8.8%
Return on Assets
3.2%
Net Margin
3.0%
Operating Margin
5.0%
Gross Profit / Assets
Novy-Marx GPA
15.8%
Debt / Equity
1.64
Current Ratio
1.19
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.037
MomentumPrice trend strength over different horizons
6M Return
43.9%
12M Return
79.0%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
42.7%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
1.11
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
36.8%
Earnings Growth (YoY)
19.2%
Earnings Stability (CV)
Lower = more stable
0.174
5yr Consistent
EPS up every year for 5 years
Yes
Piotroski F-Score
3
Buyback Yield
-0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
89
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
92
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
92
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity